TY - JOUR
T1 - Prognosis of survival among older adults with COVID-19
T2 - A systematic review and meta-analysis
AU - Saragih, Ita Daryanti
AU - Suarilah, Ira
AU - Saragih, Ice Septriani
N1 - Publisher Copyright:
© 2022 International Journal of Health Sciences.All rights reserved.
PY - 2022
Y1 - 2022
N2 - Older adults hospitalized due to COVID-19 infection are at high risk of fatality. Additional fatalities such as obesity and comorbidity tend to rapidly develop into progressive clinical deterioration. Therefore, a complex survival prognosis is urgently needed to save more older adults. This study aims to systematically examine obesity and comorbidity as a prognosis of survival in older adults with COVID-19. A Systematic review was conducted using five databases; CINAHL; EMBASE; MEDLINE; PubMed, and Web of Science. Selected papers were published between 2019 and 2020 based on a computerized search. Three reviewers reviewed the quality of the included studies using the JBI (Joanna Briggs Institute) tool for cohort study. The data were compiled using the random-effect models while heterogeneity between studies was assessed using the Cochran Q and I2 statistics. A total of 40,154 data were retrieved from 8 included studies, older adults ranging from 65 to 74-year-olds, with basal metabolism index (BMI) 30-35 kg/m2, diabetes mellitus, hypertension, chronic kidney disease (CKD), and malignancy. Predictors of survival in older adults with COVID-19 include comorbidity (61.3%), obesity (7.1%), mortality (17.3%), female (6.0%), and male (8.3%). Obesity, diabetes, hypertension, CKD, and malignancy play significant roles in the prognosis of survival among older adults with COVID-19.
AB - Older adults hospitalized due to COVID-19 infection are at high risk of fatality. Additional fatalities such as obesity and comorbidity tend to rapidly develop into progressive clinical deterioration. Therefore, a complex survival prognosis is urgently needed to save more older adults. This study aims to systematically examine obesity and comorbidity as a prognosis of survival in older adults with COVID-19. A Systematic review was conducted using five databases; CINAHL; EMBASE; MEDLINE; PubMed, and Web of Science. Selected papers were published between 2019 and 2020 based on a computerized search. Three reviewers reviewed the quality of the included studies using the JBI (Joanna Briggs Institute) tool for cohort study. The data were compiled using the random-effect models while heterogeneity between studies was assessed using the Cochran Q and I2 statistics. A total of 40,154 data were retrieved from 8 included studies, older adults ranging from 65 to 74-year-olds, with basal metabolism index (BMI) 30-35 kg/m2, diabetes mellitus, hypertension, chronic kidney disease (CKD), and malignancy. Predictors of survival in older adults with COVID-19 include comorbidity (61.3%), obesity (7.1%), mortality (17.3%), female (6.0%), and male (8.3%). Obesity, diabetes, hypertension, CKD, and malignancy play significant roles in the prognosis of survival among older adults with COVID-19.
KW - comorbidity
KW - COVID-19
KW - mortality
KW - Obesity
KW - older adult
UR - http://www.scopus.com/inward/record.url?scp=85135601369&partnerID=8YFLogxK
U2 - 10.53730/ijhs.v6nS5.9576
DO - 10.53730/ijhs.v6nS5.9576
M3 - Review article
AN - SCOPUS:85135601369
SN - 2550-6978
VL - 6
SP - 4429
EP - 4444
JO - International Journal of Health Sciences
JF - International Journal of Health Sciences
ER -
